Targeting IL-6 Receptor Signaling with Satralizumab in Thyroid Eye Disease: Design of the Phase 3 SatraGO-1 and SatraGO-2 Trials
Oluwatobi O. Idowu, Christopher Brittain, Daniel G. Ezra, Zdenka Hašková et al.
Journal
Ophthalmology and Therapy
Topics
Ophthalmology and Eye Disorders
article
Targeting IL-6 Receptor Signaling with Satralizumab in Thyroid Eye Disease: Design of the Phase 3 SatraGO-1 and SatraGO-2 Trials
Oluwatobi O. Idowu, Christopher Brittain, Daniel G. Ezra, Zdenka Hašková, Hiroaki Ida, A. Bernard Collins, Thomas Kuenzel, Miriam Triyatni
article en
Abstract
No abstract available for this paper.
Publication Tag
Ophthalmology and TherapyVol. 14(12)
Institutions
Roche (Switzerland) (CH), Gene Therapy Laboratory (FR), Fresno VA Medical Center (US), The California Eye Institute (US), Moorfields Eye Hospital (GB), University College London (GB)